Literature DB >> 28386663

A child with phenylketonuria and focal segmental glomerulosclerosis, the bright side of proteinuria.

Fatma Rabah1, Khalid Al-Thihli2, Mohamed El-Naggari3, Ibtisam B Elnour3.   

Abstract

Phenylketonuria (PKU) is the most common inborn error of amino acid metabolism. Phenylalanine hydroxylase is the underlying deficient enzyme. If left untreated, growth failure, microcephaly, global developmental delay, seizures and severe intellectual impairment would characterize the clinical picture of PKU. On the other side of protein homeostasis lies nephrotic syndrome. It is a well-known quantitative defect due to significant proteinuria. Focal segmental glomerulosclerosis (FSGS) is a special congenital variant affecting children and adults. Hereby, we describe a three- year old male child who presented with generalized edema and global developmental delay. Investigations revealed PKU along with FSGS. We assume that congenital nephrosis ameliorated the picture of PKU, and had a salutary effect on the growth and development. Such coexistence between PKU and FSGS hasn't been described before.

Entities:  

Keywords:  Brain development; FSGS; Metabolic; NPHS2; Oman; PKU

Mesh:

Year:  2017        PMID: 28386663     DOI: 10.1007/s11011-017-9998-z

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  12 in total

Review 1.  Focal and segmental glomerulosclerosis and plasma cell proliferative disorders.

Authors:  David Dingli; Dirk R Larson; Matthew F Plevak; Joseph P Grande; Robert A Kyle
Journal:  Am J Kidney Dis       Date:  2005-08       Impact factor: 8.860

Review 2.  Phenylketonuria.

Authors:  Nenad Blau; Francjan J van Spronsen; Harvey L Levy
Journal:  Lancet       Date:  2010-10-23       Impact factor: 79.321

3.  Newborn PKU screening in Turkey: at present and organization for future.

Authors:  I Ozalp; T Coşkun; A Tokatli; H S Kalkanoğlu; A Dursun; S Tokol; G Köksal; M Ozgüc; R Köse
Journal:  Turk J Pediatr       Date:  2001 Apr-Jun       Impact factor: 0.552

4.  Consanguinity, endogamy and inborn errors of metabolism in Oman: a cross-sectional study.

Authors:  Khalid Al-Thihli; Fathiya Al-Murshedi; Nadia Al-Hashmi; Watfa Al-Mamari; M Mazharul Islam; Said A Al-Yahyaee
Journal:  Hum Hered       Date:  2014-07-29       Impact factor: 0.444

5.  Phenylketonuria: MR imaging of the brain with clinical correlation.

Authors:  K D Pearsen; A D Gean-Marton; H L Levy; K R Davis
Journal:  Radiology       Date:  1990-11       Impact factor: 11.105

6.  Inborn errors of metabolism detectable by tandem mass spectrometry in Egypt: The first newborn screening pilot study.

Authors:  Fayza A Hassan; Fatma El-Mougy; Sahar A Sharaf; Iman Mandour; Marian F Morgan; Laila A Selim; Sawsan A Hassan; Fadia Salem; Azza Oraby; Marian Y Girgis; Iman G Mahmoud; Amira El-Badawy; Ibrahim El-Nekhely; Nadia Moharam; Dina A Mehaney; Mohamed A Elmonem
Journal:  J Med Screen       Date:  2016-01-20       Impact factor: 2.136

7.  Neonatal screening in Europe; the situation in 2004.

Authors:  J Gerard Loeber
Journal:  J Inherit Metab Dis       Date:  2007-07-06       Impact factor: 4.982

8.  Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?

Authors:  Peter J Anderson; Stephen J Wood; Dorothy E Francis; Lee Coleman; Vicki Anderson; Avihu Boneh
Journal:  Dev Neuropsychol       Date:  2007       Impact factor: 2.253

Review 9.  Phenylketonuria mutations in Europe.

Authors:  Johannes Zschocke
Journal:  Hum Mutat       Date:  2003-04       Impact factor: 4.878

10.  Chronic kidney disease in adolescent and adult patients with phenylketonuria.

Authors:  Julia B Hennermann; Sylvia Roloff; Jutta Gellermann; Ilka Vollmer; Elke Windt; Barbara Vetter; Ursula Plöckinger; Eberhard Mönch; Uwe Querfeld
Journal:  J Inherit Metab Dis       Date:  2012-11-09       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.